Shanghai Shengpu Zetai Pharmaceutical Technology Co.
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $16M
Investors
- 2
About Shanghai Shengpu Zetai Pharmaceutical Technology Co.
, Ltd is a biotech company providing an AI-CRDMO service platform from new drug discovery to industrial production. The company provides pharmaceutical companies with AI design and synthesis preparation of drug molecules, preclinical animal experiment validation, delivery of preclinical candidate compounds (PCCs), clinical filing of innovative drugs, and supply of API production.
Who invested in Shanghai Shengpu Zetai Pharmaceutical Technology Co.
2 investors across 1 round
See all investors in Shanghai Shengpu Zetai Pharmaceutical Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 2, 2022
Amount
$16M
Investors
Questions about Shanghai Shengpu Zetai Pharmaceutical Technology Co.
Who invested in Shanghai Shengpu Zetai Pharmaceutical Technology Co.?
Shanghai Shengpu Zetai Pharmaceutical Technology Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Shengpu Zetai Pharmaceutical Technology Co. raised?
Shanghai Shengpu Zetai Pharmaceutical Technology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shanghai Shengpu Zetai Pharmaceutical Technology Co. last raise money?
Shanghai Shengpu Zetai Pharmaceutical Technology Co.'s most recent round on record is a Series A, in Apr 2022.
What does Shanghai Shengpu Zetai Pharmaceutical Technology Co. do?
, Ltd is a biotech company providing an AI-CRDMO service platform from new drug discovery to industrial production.
Where is Shanghai Shengpu Zetai Pharmaceutical Technology Co. headquartered?
Shanghai Shengpu Zetai Pharmaceutical Technology Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Shengpu Zetai Pharmaceutical Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shanghai Shengpu Zetai Pharmaceutical Technology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Shanghai Shengpu Zetai Pharmaceutical Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.